First placement of APAS Independence into European lab
Following an extensive review of the APAS® AI technology in the Company’s facilities in Adelaide and at St Vincent’s Hospital in Melbourne, prestigious German facility Labor Dr Wisplinghoff in Cologne has commissioned its first APAS® Independence instrument. This production-ready instrument has shipped to Germany and will be commissioned by CCS technical staff with scientists at the Labor Dr Wisplinghoff facility, following the ECCMID meeting in Madrid on 21-24 April 2018.
Presentation of APAS® Evaluation at 28TH ECCMID Conference
We are pleased to announce that data detailing the performance of the APAS®
Independence in a clinical setting was presented at the ECCMID meeting by Lisa Brenton of St Vincent’s Hospital, Melbourne.
EGM Results of Meeting
Click here to see the Result of Extraordinary General Meeting
Presentation from Extraordinary General Meeting
Click here to see the presentation from the Extraordinary General Meeting by our CEO and MD Brent Barnes
Company OverviewOver the past decade, LBT Innovations has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefi...
MicroStreakIn its first five years of global sales, LBT’s MicroStreak technology captured the largest share of the international market for automated culture-plate streaking and inoculation. Originally sold by bi...
APASThe Automated Plate Assessment System, or APAS, is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculati...